Edition:
United States

Tissue Regenix Group PLC (TRX.L)

TRX.L on London Stock Exchange

19.25GBp
23 Sep 2016
Change (% chg)

0.00p (+0.00%)
Prev Close
19.25p
Open
19.25p
Day's High
--
Day's Low
--
Volume
68,015
Avg. Vol
239,215
52-wk High
22.50p
52-wk Low
12.70p

TRX.L

Chart for TRX.L

About

Tissue Regenix Group plc is a medical technology company. The Company is engaged in the development of regenerative products to make replacement native tissue using biological (human and animal) tissues. It operates through Cardiac, Wound Care and Orthopaedics divisions. Its decellularisation (dCELL) technology removes... (more)

Overall

Beta: 1.14
Market Cap(Mil.): £146.32
Shares Outstanding(Mil.): 760.12
Dividend: --
Yield (%): --

Financials

  TRX.L Industry Sector
P/E (TTM): -- 42.52 36.60
EPS (TTM): -0.01 -- --
ROI: -57.76 -0.26 13.91
ROE: -57.20 -3.05 14.82

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Edison Investment Research
$10.00
Provider : Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.